Newly identified oncolytic VSV-GP-specific CD8+ T cell epitopes for monitoring of anti-viral immune responses in the BALB/c mouse model

The vesicular stomatitis virus variant VSV-GP is an oncolytic virus (OV) platform extensively studied in preclinical settings, which recently entered clinical trial testing. For oncolytic virotherapy, innate and adaptive immune system activation are considered major contributors. However, upon OV tr...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Sarah Danklmaier, Saskia V. Vijver, Lisa Pipperger, Gabriel Floriani, Lukas Perro, Vanessa Konrad, Tamara Hofer, Hubert Hackl, Krishna Das, Guido Wollmann
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-12-01
Serie:	Molecular Therapy: Oncology
Soggetti:	MT: Regular Issue VSV CD8+ T cell epitope prediction oncolytic virus anti-viral immunity
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2950329925001419
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!